Pharmacology

bariatric, surgery, medication, use, obesity, gastric bypass, weight lossbariatric, surgery, medication, use, obesity, gastric bypass, weight loss

bariatric, surgery, medication, use, obesity, gastric bypass, weight lossbariatric, surgery, medication, use, obesity, gastric bypass, weight loss

bariatric, surgery, medication, use, obesity, gastric bypass, weight lossbariatric, surgery, medication, use, obesity, gastric bypass, weight loss

surgery, NSAIDs, nonsteroidal anti-inflammatory drugs, platelet function, ibuprofen, preoperative, withdrawalsurgery, NSAIDs, nonsteroidal anti-inflammatory drugs, platelet function, ibuprofen, preoperative, withdrawal

surgery, NSAIDs, nonsteroidal anti-inflammatory drugs, platelet function, ibuprofen, preoperative, withdrawalsurgery, NSAIDs, nonsteroidal anti-inflammatory drugs, platelet function, ibuprofen, preoperative, withdrawal

surgery, NSAIDs, nonsteroidal anti-inflammatory drugs, platelet function, ibuprofen, preoperative, withdrawalsurgery, NSAIDs, nonsteroidal anti-inflammatory drugs, platelet function, ibuprofen, preoperative, withdrawal

gastroenterology, antibiotic therapy, Crohn's disease, ileal, ileocolonic, bowel, ornidazole, adverse drug effects, interactionsgastroenterology, antibiotic therapy, Crohn's disease, ileal, ileocolonic, bowel, ornidazole, adverse drug effects, interactions

gastroenterology, antibiotic therapy, Crohn's disease, ileal, ileocolonic, bowel, ornidazole, adverse drug effects, interactionsgastroenterology, antibiotic therapy, Crohn's disease, ileal, ileocolonic, bowel, ornidazole, adverse drug effects, interactions

gastroenterology, antibiotic therapy, Crohn's disease, ileal, ileocolonic, bowel, ornidazole, adverse drug effects, interactionsgastroenterology, antibiotic therapy, Crohn's disease, ileal, ileocolonic, bowel, ornidazole, adverse drug effects, interactions

drug-disease interactions, elders, gerontology, adverse drug effects, interactions, patient safety, Geriatric Evaluation and Management trial, GEMdrug-disease interactions, elders, gerontology, adverse drug effects, interactions, patient safety, Geriatric Evaluation and Management trial, GEM

drug-disease interactions, elders, gerontology, adverse drug effects, interactions, patient safety, Geriatric Evaluation and Management trial, GEMdrug-disease interactions, elders, gerontology, adverse drug effects, interactions, patient safety, Geriatric Evaluation and Management trial, GEM

drug-disease interactions, elders, gerontology, adverse drug effects, interactions, patient safety, Geriatric Evaluation and Management trial, GEMdrug-disease interactions, elders, gerontology, adverse drug effects, interactions, patient safety, Geriatric Evaluation and Management trial, GEM

fluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risksfluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risks

fluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risksfluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risks

fluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risksfluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risks

brain death, valproic acid, overdose, venlafaxine, risperidone, cerebral edema, antiseizure drugs, adverse drug effects, interactionsbrain death, valproic acid, overdose, venlafaxine, risperidone, cerebral edema, antiseizure drugs, adverse drug effects, interactions

brain death, valproic acid, overdose, venlafaxine, risperidone, cerebral edema, antiseizure drugs, adverse drug effects, interactionsbrain death, valproic acid, overdose, venlafaxine, risperidone, cerebral edema, antiseizure drugs, adverse drug effects, interactions

brain death, valproic acid, overdose, venlafaxine, risperidone, cerebral edema, antiseizure drugs, adverse drug effects, interactionsbrain death, valproic acid, overdose, venlafaxine, risperidone, cerebral edema, antiseizure drugs, adverse drug effects, interactions

diabetic hypertension, angiotensin converting enzyme inhibitor, ACE inhibitor, angiotensin II receptor blocker, candesartan, lisinopril 20, lisinopril 40, anithypertensives, high blood pressure, hypertensiondiabetic hypertension, angiotensin converting enzyme inhibitor, ACE inhibitor, angiotensin II receptor blocker, candesartan, lisinopril 20, lisinopril 40, anithypertensives, high blood pressure, hypertension

diabetic hypertension, angiotensin converting enzyme inhibitor, ACE inhibitor, angiotensin II receptor blocker, candesartan, lisinopril 20, lisinopril 40, anithypertensives, high blood pressure, hypertensiondiabetic hypertension, angiotensin converting enzyme inhibitor, ACE inhibitor, angiotensin II receptor blocker, candesartan, lisinopril 20, lisinopril 40, anithypertensives, high blood pressure, hypertension

diabetic hypertension, angiotensin converting enzyme inhibitor, ACE inhibitor, angiotensin II receptor blocker, candesartan, lisinopril 20, lisinopril 40, anithypertensives, high blood pressure, hypertensiondiabetic hypertension, angiotensin converting enzyme inhibitor, ACE inhibitor, angiotensin II receptor blocker, candesartan, lisinopril 20, lisinopril 40, anithypertensives, high blood pressure, hypertension

gastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alphagastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alpha

gastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alphagastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alpha

gastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alphagastroenterology, adalimumab, Crohn's disease, infliximab, tumor necrosis factor alpha

pioglitazone, pulmonary edema, PE, left ventricular dysfunction, normal, left ventricular function, heart failure, thiazolidinediones, diabetes, hypertension, fluid retentionpioglitazone, pulmonary edema, PE, left ventricular dysfunction, normal, left ventricular function, heart failure, thiazolidinediones, diabetes, hypertension, fluid retention

pioglitazone, pulmonary edema, PE, left ventricular dysfunction, normal, left ventricular function, heart failure, thiazolidinediones, diabetes, hypertension, fluid retentionpioglitazone, pulmonary edema, PE, left ventricular dysfunction, normal, left ventricular function, heart failure, thiazolidinediones, diabetes, hypertension, fluid retention

pioglitazone, pulmonary edema, PE, left ventricular dysfunction, normal, left ventricular function, heart failure, thiazolidinediones, diabetes, hypertension, fluid retentionpioglitazone, pulmonary edema, PE, left ventricular dysfunction, normal, left ventricular function, heart failure, thiazolidinediones, diabetes, hypertension, fluid retention